Mechanism of thyrotoxic periodic paralysis

J Am Soc Nephrol. 2012 Jun;23(6):985-8. doi: 10.1681/ASN.2012010046. Epub 2012 Mar 29.

Abstract

The pathogenesis of thyrotoxic periodic paralysis has long been thought related to increased Na(+)-K(+) ATPase activity stimulated by thyroid hormone and/or hyperadrenergic activity and hyperinsulinemia. This mechanism alone, however, cannot adequately explain how hypokalemia occurs during acute attacks or the associated paradoxical depolarization of the resting membrane potential. Recent findings that loss of function mutations of the skeletal muscle-specific inward rectifying K(+) (Kir) channel, Kir2.6, associate with thyrotoxic periodic paralysis provide new insights into how reduced outward K(+) efflux in skeletal muscle, from either channel mutations or inhibition by hormones (adrenalin or insulin), can lead to a vicious cycle of hypokalemia and paradoxical depolarization, which in turn, inactivates Na(+) channels and causes muscle unexcitability and paralysis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Female
  • Humans
  • Hypokalemic Periodic Paralysis / drug therapy
  • Hypokalemic Periodic Paralysis / genetics
  • Hypokalemic Periodic Paralysis / physiopathology*
  • Male
  • Membrane Potentials / drug effects
  • Potassium / therapeutic use
  • Potassium Channels, Inwardly Rectifying / genetics
  • Prognosis
  • Risk Assessment
  • Severity of Illness Index
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Thyroid Function Tests
  • Thyroid Hormones / metabolism*
  • Thyrotoxicosis / physiopathology*
  • Treatment Outcome

Substances

  • Kcnj10 (channel)
  • Potassium Channels, Inwardly Rectifying
  • Thyroid Hormones
  • Sodium-Potassium-Exchanging ATPase
  • Potassium